GC Cell Corporation (KOSDAQ:144510)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Other	1.76B	2.18B	1.31B	1.14B	362.68M
Other Growth	-19.04%	65.70%	14.83%	215.44%	-7.47%
Cell Therapy	1.31B	13.80B	6.58B	7.92B	1.91B
Cell Therapy Growth	-90.49%	109.52%	-16.87%	313.85%	-
Biologistics	34.42B	25.82B	19.24B	12.21B	9.60B
Biologistics Growth	33.29%	34.23%	57.59%	27.16%	135.74%
Cell Storage	2.45B	2.51B	1.94B	1.43B	958.28M
Cell Storage Growth	-2.42%	29.55%	35.22%	49.44%	-11.50%
Product Sales	7.82B	8.40B	7.26B	5.83B	4.53B
Product Sales Growth	-6.88%	15.59%	24.59%	28.77%	42.56%
CDMO	5.06B	5.71B	7.68B	492.27M	-
CDMO Growth	-11.35%	-25.67%	1461.09%	-	-
Immuno-Anticancer Drug	38.10B	34.94B	30.67B	6.28B	-
Immuno-Anticancer Drug Growth	9.05%	13.91%	388.41%	-	-
Acceptance of Specimen Service	83.53B	94.19B	161.43B	133.00B	68.20B
Acceptance of Specimen Service Growth	-11.33%	-41.65%	21.37%	95.02%	56.30%
Total	174.45B	187.54B	236.12B	168.31B	85.56B
Total Growth	-6.98%	-20.57%	40.29%	96.71%	47.79%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
South Korea	165.68B	165.21B	219.41B	159.48B	83.27B
South Korea Growth	0.28%	-24.70%	37.58%	91.51%	44.31%
Japan	1.47B	1.54B	1.26B	335.39M	71.32M
Japan Growth	-4.12%	22.35%	274.75%	370.26%	-
Other	1.76B	666.99M	1.73B	-	4.56M
Other Growth	164.43%	-61.55%	-	-	-
USA	5.53B	20.13B	13.72B	8.50B	2.22B
USA Growth	-72.51%	46.72%	61.38%	283.70%	-
Total	174.45B	187.54B	236.12B	168.31B	85.56B
Total Growth	-6.98%	-20.57%	40.29%	96.71%	47.79%

Source: S&P Global Market Intelligence.